Stephen Doster

  • Vanderbilt University

    Chikungunya antibody identified by Crowe lab moves forward

    Mar. 4, 2021, 8:54 AM   by Bill Snyder Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. This is the second monoclonal antibody against the debilitating tropical… Read More

    Mar. 4, 2021

  • Vanderbilt University

    Steve Townsend wins Sloan Research Fellowship

    by Ann Marie Deer Owens Feb. 16, 2021, 9:22 AM Assistant Professor of Chemistry Steven Townsend (Susan Urmy/Vanderbilt) Assistant Professor of Chemistry Steven D. Townsend, PhD’10, has been awarded a 2021 Sloan Research Fellowship, one of the highest honors for young… Read More

    Mar. 3, 2021

  • Vanderbilt University

    Bordenstein elected to American Academy of Microbiology

    by Ann Marie Deer Owens Mar. 2, 2021, 5:30 PM Seth Bordenstein (Vanderbilt University) Seth Bordenstein, Centennial Professor of Biological Sciences, has been elected to fellowship in the American Academy of Microbiology, the honorific leadership group within one of the… Read More

    Mar. 3, 2021

  • Vanderbilt University

    Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

    by Marissa Shapiro Feb. 25, 2021, 8:00 AM A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Jerod Denton Craig Lindsley… Read More

    Feb. 26, 2021

  • Vanderbilt University

    Despite limitations of pandemic, research continues in Basic Sciences

    Feb. 24, 2021, 8:00 AM By Jenna Somers Vanderbilt researchers are prolific and resolute in their pursuit of transformative research and innovation. During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. On… Read More

    Feb. 24, 2021

  • Vanderbilt University

    Calcification after severe injury

    Feb. 23, 2021, 8:00 AM by Emily Stembridge Patients with severe injuries, such as level 1 trauma or burns, face many complications of calcification during recovery. One is loss of bone, or osteoporosis. Another is calcification of soft tissue, resulting in heterotopic… Read More

    Feb. 23, 2021

  • Vanderbilt University

    Christov & Westover Receive Research Staff Awards

    Research Staff Awards honor those who help drive engines of discovery Feb. 18, 2021, 9:57 AM   by Bill Snyder Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 17th annual Research Staff Awards, held virtually this year because of the… Read More

    Feb. 22, 2021

  • Vanderbilt University

    Genetic clues in eye birth defect

    Feb. 18, 2021, 11:00 AM by Leigh MacMillan Uveal coloboma can affect the iris — the colored part of the eye — giving it a keyhole appearance. (iStock) Uveal coloboma — a birth defect that causes a malformation of the eye — accounts for up to 10% of childhood blindness. Read More

    Feb. 18, 2021

  • Vanderbilt University

    Dean’s Faculty Fellows program recognizes Neuert, Ren

    By Lorena Infante Lara, February 15, 2021 Assistant Professor of Biochemistry Yi Ren and Assistant Professor of Molecular Physiology and Biophysics Gregor Neuert have been recognized as School of Medicine Basic Sciences Dean’s Faculty Fellows. Established in 2020, the Dean’s Faculty Fellows program in Basic Sciences is designed to recognize… Read More

    Feb. 17, 2021

  • Vanderbilt University

    SARS-CoV-2 protein blocks an essential step in host gene expression, new discovery finds

    by Marissa Shapiro Feb. 17, 2021, 9:00 AM Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens… Read More

    Feb. 17, 2021